CV Sciences

(OTC: CVSI)
Healthcare  |  Drug Manufacturers - Specialty & Generic
5.02 0.19 3.93%
Stock Price | Dec. 7, 2018, 3:59 p.m.
7 Followers
Bid: 4.98
Ask: 6.62
Prev. Close: 4.83
52 Week Low:
52 Week High:
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

CV Sciences Inc operates in two distinct segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic cannabidiol and a consumer product division manufacturing, marketing and selling plant based CBD products to a range of market sectors.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Weekend Edition 12/10/18

53 Comments
Yesterday
1 week ago

Premium A Look at Profitability of 13 Top Cannabis Companies by Revenue

37 Comments
1 week ago
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 12/03/18

30 Comments
1 week ago

Premium Cannabis Stocks Review - AM Edition 11/30/18

107 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 11/30/18

6 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 11/29/18

83 Comments
1 week ago

Premium Cannabis Stocks Review - AM Edition 11/28/18

4 Comments
1 week ago

Premium Toking Tuesday Chat - 11/27/18

7 Comments
1 week ago